About AbbVie  
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.  
*This position is open to remote work
The Manager, Labeling Regulatory Affairs Strategic Labeling, develops and maintains US/EU package inserts and Company Core Data Sheets and coordinates review and approval of these documents with changing regulatory environments. Leads discussions to ensure global consistency of labeling. Educates team members concerning global consistency of labeling.
  * Leads teams on labeling decisions based on knowledge of processes and regulations. Educates others as to new labeling regulations regarding Company core Data Sheet (CCDS), US Package Insert (USPI), Summary of Product Characteristics (SmPC), Structured Product Labeling (SPL), or Instructions for Use ( IFUs)
  * Reviews and assesses data to determine whether accurate and reproducible. Works with clinical and safety teams to assure revised data is included as support documentation following approvals. Provides labeling input for Risk Management Plans, Regulatory Strategic & Tactical Plans (RSTPs) and safety documents
  * Drives strategic labeling processes within teams based on knowledge of success with other products. Makes recommendations to proactively optimize label language, including effective use of Target Product Label (TPL) and Development Core Data Sheets (DCDS) as applicable, for assigned products
  * Maintains accurate files of labeling change history and associated documents, including annotations to data sources
  * Participates at team meetings, reviews materials, authors documents and meets timelines. Leads cross-functional teams to resolve labeling issues and address Ministry of Health (MOH) requests globally
  * Works with safety groups on safety issues and leads discussion on safety related labeling changes. Makes decisions on own topics and those of direct reports based on experience with various products. Understands and supports regulatory implications of product profile.
  * Works strategically with R&D;, Global Medical Affairs and safety to maintain accurate safety profiles for assigned products
  * Works with Labeling Operations to ensure quality documents are internally maintained or submitted to FDA
  * Provides labeling support to Asset Development Team (ADTs) and affiliates including pre-approvals, renewals, and competitive analysis
  * May indirectly manage work of other department members. Assists in training of new personnel and in the development of department processes/policies.
Qualifications  
  * Required Education: Bachelors degree in Pharmacy, Biology, Chemistry, pharmacology or related subject
  * Preferred Education: Bachelors degree. Certifications a plus
  * Required Experience: 6 years in Pharmaceutical, regulatory, R&D; or industry related area. Experience in labeling or area that could link to labeling
  * Ability to supervise projects and set daily priorities. Able to work in a complex and matrix environment
  * Preferred Experience: 3 years in pharmaceutical or regulatory preferred. Minimum 3 years experience in clinical or pharmaceutical preferred
  * Cross-divisional team experience and working with cross-functional teams
  * Strong problem solving with minimal guidance
  * Note: Higher education may compensate for years of experience
Significant Work Activities  
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)  
Keyboard use (greater or equal to 50% of the workday)  
Travel  
Yes, 5 % of the Time  
Job Type  
Experienced  
Schedule  
Full-time  
Job Level Code  
M  
Equal Employment Opportunity  
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.